Skip to main content
Apply for Grants

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

  • ${value}

Filter Results (2292${count})

  • Research Grant, 2023
    Development of a Protein Biomarker Panel to Measure Parkinson’s Disease Heterogeneity and Progression

    Study Rationale: According to The Michael J. Fox Foundation, the need for biomarkers that provide an objective assessment for Parkinson’s disease (PD) “has become more urgent as more projects enter...

  • Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program, 2023
    Interrogating LRRK2 Variants Common in Asian Populations to Discover Unique Biomarkers for Parkinson’s Disease

    Study Rationale: Mutations in the LRRK2 gene are the most common genetic cause of Parkinson's disease (PD). Many studies have focused on the LRRK2 G2019S mutation found in Caucasians, and less is...

  • Parkinson’s Disease Therapeutics Pipeline Program, 2023
    Development of Parkin Activators for the Treatment of Parkinson’s Disease

    Study Rationale: Impaired function of cell structures called mitochondria plays a key role in the pathology of Parkinson’s disease (PD): alpha-synuclein accumulation damages mitochondria, dopamine...

  • Research Grant, 2023
    Subtyping Parkinson’s Disease Using Genetic and Intestinal Inflammation Biomarkers

    Study Rationale: Although Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide, no drugs are currently available to treat or prevent the condition because the...

  • Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program, 2023
    Targeting a Phospholipid Unique to Mitochondrial Membranes as a Therapeutic for Parkinson’s Disease

    Study Rationale: Mitochondria are energy-generating structures vital to the health of all cells. In Parkinson’s disease (PD), mitochondrial dysfunction leads to neuronal degeneration and to the motor...

  • Circuits & Cellular Targets for PD’s Symptoms, 2023
    Unbiased Identification of New Targets for Deep Brain Stimulation to Treat Gait and Balance Impairments in Parkinson’s Disease

    Study Rationale: Over time, people with Parkinson’s disease (PD) develop problems with their ability to walk that can cause serious injuries and curtail their independence. Mice with a particular...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.